← All diseases
Muscles and connective tissue
Severe myasthenia gravis
Would you like to receive a message when there is new research on Severe myasthenia gravis? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication you'll see one sentence explaining what was researched — and you'll be notified as soon as there is new research on Severe myasthenia gravis. View what Premium costs.
Publications and studies (1470)
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Autoimmune Encephalitis Induced by SARS-CoV-2 Infection Treated with Thymectomy. (2024/05/28) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Treatment Approaches to Myasthenia Gravis and Obstructive Sleep Apnea: Case Report. (2024/05/15) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Acupuncture and moxibustion treatment for myasthenia gravis: A systematic review and meta-analysis. (2024/05/03) ♡
- LEMG Findings of Vocal Fold Paresis in Voice Patients Who Play or Played Wind Instruments. (2024/05/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Unique association of anti-GABA(A) receptor encephalitis and myasthenia gravis in a patient with type A thymoma. (2024/05/01) ♡
- Current state of research on exercise for the treatment of myasthenia gravis: A scoping review. (2024/05/01) ♡
- Explainable machine learning model for identifying key gut microbes and metabolites biomarkers associated with myasthenia gravis. (2024/04/10) ♡
- The assessment of the perceived stress and the quality of life in the patients with myasthenia gravis: The mediating role of the psychological capital and social support. (2024/04/03) ♡
- Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Long-term safety and efficacy of cipaglucosidase alfa plus miglustat in individuals living with Pompe disease: an open-label phase I/II study (ATB200-02). (2024/04/01) ♡
- Rethinking the Likelihood of Myasthenia Gravis Exacerbations. (2024/04/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Disruption of Neuromuscular Junction Following Spinal Cord Injury and Motor Neuron Diseases. (2024/03/20) ♡
- Test-Retest Reliability of Repetitive Ocular Vestibular Evoked Myogenic Potentials in Myasthenia Gravis Patients and Healthy Control Subjects. (2024/03/01) ♡
- Concomitant Seropositive Ocular Myasthenia and Biopsy-Proven Temporal Arteritis. (2024/03/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Eculizumab for myasthenic exacerbation during treatment with immune-checkpoint inhibitors. (2024/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The role of artificial intelligence in electrodiagnostic and neuromuscular medicine: Current state and future directions. (2024/03/01) ♡
- Pregnancy planning may impact maternal and neonatal outcomes in people with myasthenia gravis. (2024/03/01) ♡
- Macrophage migration inhibitory factor: A novel biomarker upregulates in myasthenia gravis and correlates with disease severity and relapse. (2024/03/01) ♡
- Environmental factors affecting the risk of generalization for ocular-onset myasthenia gravis: a nationwide cohort study. (2024/02/26) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. LRP4-related signalling pathways and their regulatory role in neurological diseases. (2024/02/15) ♡
- Rs1800629 polymorphism in TNF-alpha is associated with the susceptibility and initial short-term glucocorticoids efficacy in myasthenia gravis patients. (2024/02/15) ♡
- Impact of the COVID-19 Pandemic on People Living With Rare Diseases and Their Families: Results of a National Survey. (2024/02/14) ♡
- Identification of key genes as potential diagnostic and therapeutic targets for comorbidity of myasthenia gravis and COVID-19. (2024/02/07) ♡
- Incidence and prevalence of myasthenia gravis in the United States: A claims-based analysis. (2024/02/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Bilateral hemidiaphragm atrophy and electrical myotonia in anti-muscle specific tyrosine kinase myasthenia gravis. (2024/02/01) ♡
- Diaphragmatic ultrasonography as a predictor of respiratory muscle fatigue in myasthenia gravis. (2024/02/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Clinical outcome and peripheral immune profile of myasthenic crisis with omicron infections: A prospective cohort study. (2024/02/01) ♡
- Anemia in patients undergoing chronic therapeutic plasma exchange. (2024/02/01) ♡
- Sound-based cough peak flow estimation in patients with neuromuscular disorders. (2024/02/01) ♡
- Hospitalizations and Mortality From Myasthenia Gravis: Trends From 2 US National Datasets. (2024/01/23) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Safety and Efficacy of Nipocalimab in Patients With Generalized Myasthenia Gravis: Results From the Randomized Phase 2 Vivacity-MG Study. (2024/01/23) ♡
- Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis. (2024/01/17) ♡
- High indirect bilirubin levels as an independent predictor of postoperative myasthenic crisis: a single-center, retrospective study. (2024/01/12) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Parkinson's disease and comorbid myasthenia gravis: a case report and literature review. (2024/01/08) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Have one's view of the important overshadowed by the trivial: chronic progressive external ophthalmoplegia combined with unilateral facial nerve injury: a case report and literature review. (2024/01/05) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Effects of acupuncture treatment for myasthenia gravis: A systematic review and meta-analysis. (2024/01/02) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Subcutaneous batoclimab in generalized myasthenia gravis: Results from a Phase 2a trial with an open-label extension. (2024/01/01) ♡
- Healthcare resource utilization, costs and treatment associated with myasthenia gravis exacerbations among patients with myasthenia gravis in the USA: a retrospective analysis of claims data. (2024/01/01) ♡
- Eliciting Exploratory Patient Preference Data: A Case Study in a Rare Disease. (2024/01/01) ♡
- Evaluation of Medication Exposure on Exacerbation of Disease in Patients With Myasthenia Gravis. (2024/01/01) ♡
- Myasthenia gravis and numb chin syndrome with lung carcinoma. (2024/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. A Focus on Myasthenic Ptosis: The Interface of Medical and Surgical Treatment. (2024/01/01) ♡
- [Clinical and epidemiological characteristics of myasthenia in the Altai region]. (2024/01/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Pilot Study: Use of the Saccadometer to Detect Characteristic Saccadic Peak Velocity in Myasthenia Gravis Patients (2024-12-18) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Phase 3 Open-Label Study of Eculizumab in Pediatric Participants With Refractory Generalized Myasthenia Gravis (gMG) (2024-12-11) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Telitacicept and Low-dose Steroids in Refractory Myasthenia Gravis (2024-12-09) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Characteristics and Prognostic Outcomes of Diaphragmatic Ultrasound in Myasthenia Gravis (2024-11-27) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases (2024-11-14) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Intravenous Human IgG1 Fc Fragment (Efgartigimod) in Myasthenic Crisis (2024-11-14) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Blinatumomab in Refractory Myasthenia Gravis (BLINA-MG) (2024-11-12) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Markers of Favorable Response to FcRn Inhibitors (INFORM) (2024-11-12) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.